Results 71 to 80 of about 11,507 (279)

Serological Evidence of Orthopoxvirus Infection in Neotropical Primates in Brazil

open access: yesPathogens, 2022
The genus Orthopoxvirus (OPXV) of the family Poxviridae comprises several viruses that are capable of infecting a wide range of hosts. One of the most widespread OPXVs is the Vaccinia virus (VACV), which circulates in zoonotic cycles in South America ...
Filipe V. S. Abreu   +24 more
semanticscholar   +1 more source

Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy [PDF]

open access: yes, 2017
The use of high-dose interleukin-2 (IL-2) has fallen out of favor due to severe life-threatening side effects. We have recently described a unique way of directly targeting IL-2 to cytotoxic lymphocytes using a virally encoded immune evasion protein and ...
Fremont, Daved H   +6 more
core   +2 more sources

Orthopoxvirus infection transmitted by a domestic cat

open access: yesJournal of the American Academy of Dermatology, 2006
The variola virus was declared eradicated by the World Health Organization in 1980 but human infections by cowpox virus, another member of the genus Orthopoxvirus, are still observed, mainly in European countries. We report a woman who presented with two umbilicated vesicles surrounded by an indurated erythematous edema within cat scratch injuries on ...
Haenssle, Holger Andreas   +5 more
openaire   +4 more sources

Apparition de lésions proches de la variole bovine chez des bovins en Israël

open access: yesRevue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1996
Les auteurs décrivent deux formes cliniques différentes de variole bovine apparues sporadiquement dans un troupeau laitier et dans un troupeau à viande.
I. Yeruham   +3 more
doaj   +1 more source

Development of a Loop-Mediated Isothermal Amplification Method for Rapid and Visual Detection of Monkeypox Virus

open access: yesMicrobiology Spectrum, 2022
Monkeypox virus (MPXV) is a human pathogenic virus that belongs to the genus Orthopoxvirus. In 2022, MPXV caused an unprecedented number of infections in many countries.
Junxia Feng   +18 more
doaj   +1 more source

A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge

open access: yesJournal of Virology, 2021
The eradication of smallpox and subsequent cessation of vaccination have left a majority of the population susceptible to variola virus or other emerging poxviruses. This is exemplified by human monkeypox, as evidenced by the increase in reported endemic
E. Mucker   +8 more
semanticscholar   +1 more source

Detection of minority variants within bovine respiratory syncytial virus populations using oligonucleotide-based microarrays [PDF]

open access: yes, 2008
Microarray technology, originally developed for highly parallel examination of gene expression is regarded as a potential tool in prognosis and diagnosis.
Baranowski, Eric   +4 more
core   +1 more source

Orthopoxvirus Targets for the Development of Antiviral Therapies [PDF]

open access: yesCurrent Drug Target -Infectious Disorders, 2005
The potential use of smallpox virus as a bioterror agent and the endemic presence of monkeypox virus in Africa underscores the need for better therapies for orthopoxvirus infections. The only existing clinical experience treating vaccinia and smallpox infections has been with Marboran, which suggested that antiviral therapies could be effective in ...
Earl R. Kern, Mark N. Prichard
openaire   +3 more sources

Monkeypox: An alarming global health emergency

open access: yesAPIK Journal of Internal Medicine, 2022
Monkeypox (MPX) virus is an orthopoxvirus that causes human MPX, a viral disease with symptoms indistinguishable to smallpox, which includes fever and rash.
Vasantha Kamath   +2 more
doaj   +1 more source

An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications

open access: yesExpert Review of Anti-Infective Therapy, 2020
Introduction Tecovirimat (TPOXX®; ST-246) was approved for the treatment of symptomatic smallpox by the USFDA in July of 2018 and has been stockpiled by the US government for use in a smallpox outbreak.
Andrew T. Russo   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy